Stephan Brons

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

Tumour-associated macrophages as treatment targets in oncology

A systematic review of publications on charged particle therapy for hepatocellular carcinoma

Immunologically augmented cancer treatment using modern radiotherapy

Nanotechnology for Multimodal Synergistic Cancer Therapy

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines

Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines – does scheduling matter?

Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response

Quantification of the Relative Biological Effectiveness for Ion Beam Radiotherapy: Direct Experimental Comparison of Proton and Carbon Ion Beams and a Novel Approach for Treatment Planning

In vitro sensitivity of malignant melanoma cells lines to photon and heavy ion radiation